“Immune infusions are not a ready-made cocktail but are mixed individually for the patient after a detailed medical history ...

A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy ...

Jet lag is a common travel nuisance that can turn an exciting journey into an exhausting ordeal. It occurs when there’s a mismatch between your internal body clock and the new time zone you’re in.

Baxter International plans to exit China’s intravenous fluids market, multiple local media outlets report, citing a letter to ...

IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of Fortune’s 100 Fastest Growing Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance ...

North Carolina hospitals reeling from Hurricane Helene may soon get some relief from a critical IV fluid shortage ... date on multiple types of intravenous and sterile fluids made by Baxter ...

Hurricane Helene wrecked a Baxter International factory that produced 60 percent of the country’s IV fluids. Nearly 25,000 people who need IV nutrition are scrambling.

MaineHealth Franklin Hospital held a ribbon cutting and open house for the newly renovated Cancer Care and IV Therapy center.

Principal treatment-related toxicities that come from amivantamab administration include skin-related reactions, higher risk of venous thrombolism, and infusion-related reactions.

ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced the nationwide rollout of its ...

Celltrion USA has expanded access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous (SC) infliximab, to a significant share of the U.S. market ...